ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Debt | ₹772 Cr | ₹562 Cr | ₹837 Cr | ₹1,154 Cr |
What is the latest Total Debt ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹772 Cr |
| Mar2024 | ₹562 Cr |
| Mar2023 | ₹837 Cr |
| Mar2022 | ₹1,154 Cr |
How is Total Debt of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹772 Cr | 37.25 | |
| Mar2024 | ₹562 Cr | -32.81 | |
| Mar2023 | ₹837 Cr | -27.51 | |
| Mar2022 | ₹1,154 Cr | - | |
Compare Total Debt of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,525.2 Cr | -2.6% | -5.2% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -2.6% |
-5.2% |
-20% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses